Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems
about
Asthma-COPD overlap syndrome (ACOS): A diagnostic challengeClinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease.What pulmonologists think about the asthma-COPD overlap syndrome.Is a previous diagnosis of asthma a reliable criterion for asthma-COPD overlap syndrome in a patient with COPD?Cost-effectiveness of combination therapy umeclidinium/vilanterol versus tiotropium in symptomatic COPD Spanish patients.Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK.Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies.Asthma and Chronic Obstructive Pulmonary Disease Overlap: The Effect of Definitions on Measures of Burden.Asthma and chronic obstructive pulmonary disease overlap: asthmatic chronic obstructive pulmonary disease or chronic obstructive asthma?Understanding COPD-overlap syndromes.Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.Characteristics of COPD patients according to GOLD classification and clinical phenotypes in the Russian Federation: the SUPPORT trial.A Cross-sectional Assessment of Health-related Quality of Life among Patients with Chronic Obstructive Pulmonary Disease.The Prevalence and Symptom Profile of Asthma-COPD Overlap: The HUNT Study.Clinical characteristics of COPD syndrome: A 6-year follow-up study of adult smokers.Prevalence of smoking in a psychiatric hospital and its relationship with respiratory symptoms and the prevalence of COPD
P2860
Q26785749-0CDBC463-6BDC-45B4-A6F4-78C96BE9BBF9Q35111195-6A3B1EBF-23F4-4E83-AD02-BE115304E700Q35867095-BB2C3B01-19D9-4D16-AEDD-3E0FBEDC5119Q36036910-1D331EFB-3C71-4B68-93AC-EF4766133690Q36490676-A0AEC741-44D3-464E-8B12-CB643B4EE606Q37012197-3E4A523F-6AD1-434D-81A5-4FACD6B23585Q37090104-4A77157D-24FD-49A6-B340-D8ABC4C65196Q38604609-CB7142BA-1019-4C9B-9CE4-E5D9D6BD6560Q38644007-86241A80-584C-484A-AB4E-A830C17FD3CCQ39173255-3C67B963-B189-4017-B7C0-0F0032CEC3DEQ41405463-D6DB7C9C-7110-48F1-B8D7-AFDF3C97EAB7Q47096612-38256D48-8C66-496E-AAC3-0A5826DA7954Q47250181-FC7E4F20-C0E9-4EE7-8B09-907BA4318240Q47676677-79B61F3F-6656-47E5-A1DF-A1911ACE9280Q51612448-430C0A4E-E294-471E-936E-ABECD81E1A1FQ57777307-70481040-B54E-44B4-9C17-08C1821BAE83
P2860
Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Generic utilities in chronic o ...... g to different staging systems
@ast
Generic utilities in chronic o ...... g to different staging systems
@en
Generic utilities in chronic o ...... g to different staging systems
@nl
type
label
Generic utilities in chronic o ...... g to different staging systems
@ast
Generic utilities in chronic o ...... g to different staging systems
@en
Generic utilities in chronic o ...... g to different staging systems
@nl
prefLabel
Generic utilities in chronic o ...... g to different staging systems
@ast
Generic utilities in chronic o ...... g to different staging systems
@en
Generic utilities in chronic o ...... g to different staging systems
@nl
P2093
P2860
P50
P1476
Generic utilities in chronic o ...... g to different staging systems
@en
P2093
Alicia Huerta
Carlos Crespo
Francisco García-Río
Guillermo Villa
José Alberto Fernández-Villar
Maribel Cuesta
P2860
P2888
P356
10.1186/S12955-014-0120-5
P577
2014-09-05T00:00:00Z
P5875
P6179
1043272853